Use: Neuromidin is used for diseases of the peripheral nervous system, such as mono- and polyneuropathies, polyradiculopathies, myasthenia, and myasthenic syndrome of various etiologies. It is also used for diseases of the central nervous system: bulbar palsies and pareses, as well as during the recovery period of organic CNS lesions accompanied by motor disorders. How to take: The drug is administered subcutaneously or intramuscularly. Doses and duration of treatment are determined individually depending on the severity of the disease. - For mono- and polyneuropathy, polyradiculopathy of various etiologies, myasthenia, and myasthenic syndrome: subcutaneously or intramuscularly 5-15 mg 1-2 times a day. The course of treatment is 10-15 days (in severe cases up to 30 days); thereafter, treatment is continued with ipidacrine for oral administration. - For bulbar palsies and pareses: subcutaneously or intramuscularly 5-15 mg 1-2 times a day for 10-15 days; if possible, switch to oral administration. - For rehabilitation in organic CNS lesions: intramuscularly 10-15 mg 1-2 times a day, course up to 15 days; thereafter, if possible, switch to oral administration. If necessary, treatment can be repeated several times with an interval of 1-2 months between courses. Contraindications: Hypersensitivity to ipidacrine or excipients of the drug, epilepsy, vestibular disorders, extrapyramidal disorders with hyperkinesis, angina pectoris, pronounced bradycardia, bronchial asthma, peptic ulcer of the stomach or duodenum in the acute phase, mechanical obstruction of the intestines and/or urinary tract, pregnancy (the drug increases uterine tone), lactation (breastfeeding period). Storage: Store in the original packaging at a temperature not exceeding 25 degreeC. Keep out of reach of children.